Linden Thomas Advisory Services’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.67M | Sell |
63,600
-92
| -0.1% | -$6.75K | 0.51% | 37 |
|
|
2025
Q1 | $7.27M | Buy |
63,692
+468
| +0.7% | +$53.5K | 0.94% | 5 |
|
|
2024
Q4 | $3.19M | Buy |
63,224
+1,300
| +2% | +$65.5K | 0.4% | 52 |
|
|
2024
Q3 | $2.87M | Buy |
61,924
+1,051
| +2% | +$48.6K | 0.39% | 57 |
|
|
2024
Q2 | $1.98M | Buy |
60,873
+2,002
| +3% | +$65K | 0.31% | 94 |
|
|
2024
Q1 | $1.48M | Buy |
58,871
+2,200
| +4% | +$55.4K | 0.24% | 171 |
|
|
2023
Q4 | $1.84M | Buy |
56,671
+555
| +1% | +$18K | 0.34% | 86 |
|
|
2023
Q3 | $1.53M | Buy |
56,116
+368
| +0.7% | +$10K | 0.34% | 100 |
|
|
2023
Q2 | $1.24M | Buy |
+55,748
| New | +$1.24M | 0.28% | 142 |
|